UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
|
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Delaware
(State or Other Jurisdiction
of Incorporation)
|
002-90539
(Commission File Number)
|
59-2262718
(IRS Employer
Identification No.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
|
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 40.14d - (b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e - (c))
|
In connection with the Annual Meeting of Stockholders of Applied DNA Sciences, Inc. to be held on August 28, 2014, a Notice and Proxy Statement (the "Proxy Statement") was mailed to all stockholders of record as of July 11, 2014.
The Proxy Statement is furnished as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 8.01 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended.
99.1
|
Notice
and Proxy Statement for Annual Meeting of Stockholders to be held on August 28, 2014.
|
Applied DNA Sciences, Inc.
|
||
(Registrant)
|
||
By:
|
/s/ James A. Hayward
|
|
James A. Hayward
|
||
Chief Executive Officer
|
||
Exhibit No.
|
Description
|
|
99.1
|
Notice
and Proxy Statement for Annual Meeting of Stockholders to be held on August 28, 2014.
|